CCL Products (India) (CCL) investor relations material

Executive summary

• Achieved Q3 turnover of INR 1,053 crore (Rs. 1,05,056.46 lakhs), up 38% year-over-year; nine-month turnover at INR 3,239.41 crore (Rs. 3,23,292.96 lakhs), up 42% year-over-year.

• Q3 net profit at INR 100.26 crore (Rs. 10,026.78 lakhs), up 59% year-over-year; nine-month net profit at INR 273.57 crore (Rs. 27,357.38 lakhs), up 31% year-over-year.

• Domestic branded sales for Q3 at INR 120 crore and nine months at INR 330 crore, with strong growth momentum.

• Interim dividend of INR 2.75 per equity share declared for FY 2025-26, with record date set for February 10, 2026.

• Un-audited standalone and consolidated financial results for Q3 and nine months ended December 31, 2025, were approved and reviewed by statutory auditors with unmodified reports.

Financial highlights

• Q3 EBITDA at INR 187.56 crore, up 47% year-over-year; nine-month EBITDA at INR 547.6 crore, up 38%.

• Q3 PBT at INR 116.27 crore, up 62% year-over-year; nine-month PBT at INR 337.55 crore, up 37%.

• EBITDA per kg improved to INR 135-140, with guidance to maintain these levels.

• Free cash flow for TTM at INR 700 crore, expected to improve further.

• Standalone and consolidated EPS show strong year-over-year growth.

Outlook and guidance

• Volume growth guidance remains at 18%-20% for the year; next year guidance to be updated post market developments.

• EBITDA growth guidance revised to approximately 25% for the year, with 15%-20% targeted for next year, pending market conditions.

• Capacity utilization expected to reach 85%-90% in two years, with future expansion plans under consideration.

• Management continues to monitor regulatory changes, especially new Labour Codes, and has made provisions for potential impacts.